ROSENBLUM MARK J (Exec VP Finance, Interim CFO) received a stock award from DECOY THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/5/2023ACC: 0001615219-23-000004
Officer· Exec VP Finance, Interim CFO
Since Sep 2019
+8K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
8K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+8K
Price / share
—
Trade value
—
% of position
107.8%
1/3/2023
7.42K→15.42K
Total
Net shares
+8K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2023 | A · Award | +8K | — | — | 107.8% | 7.42K | 15.42K |
| Total | +8K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported